Antiretroviral therapy (ART) dramatically reduces mortality due to HIV. Poor adherence to medication is a major barrier to successful treatment. High rates of mental illness, substance use, and unstable housing make adherence particularly problematic in the urban poor. We propose to carry out a three arm, randomized controlled study of two interventions aimed at improving adherence to ART in the urban poor: 1) Adherence Case Management (ACM) and 2) Modified Directly Observed Therapy (MDOT). 336 homeless and marginally housed HIV individuals on either once-daily or twice-daily combination antiretroviral therapy with detectable viral loads and 430% pill count adherence will be randomized to each condition (1 12 per condition). The ACM intervention will be delivered as part of an ongoing adherence support program funded by the San Francisco Department of Public Health. The MDOT program will be operated at our current storefront research site in the Tenderloin District of San Francisco. Adherence to HIV antiretroviral therapy will be measured by unannounced pill count and an audio-CAS1 patient interview method. We will investigate the impact of these two interventions on four specific areas: 1) adherence to antiretroviral therapy, 2) changes in HIV- 1 viral load, 3) development of viral resistance, and 4) cost effectiveness of the interventions. Outcomes will be assessed quarterly during the 6-month intervention and during a 6 month post-intervention period to examine the durability of the intervention effect.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-AARR-7 (01))
Program Officer
Stirratt, Michael J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
Internal Medicine/Medicine
Schools of Medicine
San Francisco
United States
Zip Code
Bangsberg, David R (2009) Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naïve patients. Curr HIV/AIDS Rep 6:173-4
Volpp, Kevin G; Pauly, Mark V; Loewenstein, George et al. (2009) P4P4P: an agenda for research on pay-for-performance for patients. Health Aff (Millwood) 28:206-14
Bourgois, Philippe (2008) The mystery of marijuana: science and the U.S. War on Drugs. Subst Use Misuse 43:581-3
Weiser, Sheri D; Riley, Elise D; Ragland, Kathleen et al. (2006) Brief report: Factors associated with depression among homeless and marginally housed HIV-infected men in San Francisco. J Gen Intern Med 21:61-4
Weiser, Sheri D; Wolfe, William R; Bangsberg, David R (2004) The HIV epidemic among individuals with mental illness in the United States. Curr HIV/AIDS Rep 1:186-92
Weiser, Sheri D; Guzman, David; Riley, Elise D et al. (2004) Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherence. HIV Clin Trials 5:278-87
Giordano, Thomas P; Guzman, David; Clark, Richard et al. (2004) Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 5:74-9